NanoString Technologies (NSTG) Updates FY18 Earnings Guidance

NanoString Technologies (NASDAQ:NSTG) updated its FY18 earnings guidance on Wednesday. The company provided EPS guidance of (2.90)-($2.60) for the period, compared to the Thomson Reuters consensus EPS estimate of ($2.48).

Several equities analysts have issued reports on the company. Morgan Stanley reaffirmed an equal weight rating and set a $12.00 price objective (down previously from $13.00) on shares of NanoString Technologies in a report on Thursday, March 8th. ValuEngine lowered NanoString Technologies from a sell rating to a strong sell rating in a report on Friday, February 2nd. Finally, Zacks Investment Research lowered NanoString Technologies from a buy rating to a hold rating in a report on Thursday, January 11th. Two equities research analysts have rated the stock with a sell rating, four have assigned a hold rating and one has issued a buy rating to the company. The stock presently has an average rating of Hold and a consensus price target of $13.06.

Shares of NanoString Technologies (NASDAQ:NSTG) traded down $0.08 during mid-day trading on Wednesday, hitting $6.93. The company’s stock had a trading volume of 912,396 shares, compared to its average volume of 234,452. The stock has a market capitalization of $172.49, a price-to-earnings ratio of -3.73 and a beta of 0.91. NanoString Technologies has a 12 month low of $5.87 and a 12 month high of $20.70. The company has a debt-to-equity ratio of 1.22, a quick ratio of 2.84 and a current ratio of 3.40.

NanoString Technologies (NASDAQ:NSTG) last released its quarterly earnings results on Wednesday, March 7th. The biotechnology company reported ($0.34) earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of ($0.42) by $0.08. NanoString Technologies had a negative return on equity of 129.90% and a negative net margin of 37.91%. The firm had revenue of $35.20 million for the quarter, compared to analyst estimates of $31.57 million. During the same quarter last year, the company posted ($0.55) earnings per share. The business’s revenue was up 39.7% on a year-over-year basis. research analysts forecast that NanoString Technologies will post -2.79 EPS for the current fiscal year.

TRADEMARK VIOLATION NOTICE: This news story was first published by The Lincolnian Online and is the property of of The Lincolnian Online. If you are viewing this news story on another publication, it was illegally stolen and republished in violation of U.S. & international copyright law. The legal version of this news story can be read at

NanoString Technologies Company Profile

NanoString Technologies, Inc develops, manufactures and sells intuitive products that unlock scientifically valuable and clinically actionable biologic information from minute amounts of tissue. The Company is engaged in the development, manufacture and commercialization of instruments, consumables and services for profiling the activity of hundreds of genes and proteins simultaneously from a single tissue sample.

Receive News & Ratings for NanoString Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NanoString Technologies and related companies with's FREE daily email newsletter.

Leave a Reply